Characteristics, risk factors, and outcomes of bloodstream Candida infections in the intensive care unit: a retrospective cohort study

Objective The main objective was to assess the clinical characteristics, associated factors, and outcomes of patients admitted to the ICU for candidemia. The secondary objective was to examine the relationship of candidemia with the length of stay and mortality. Methods The analysis was a retrospective single-center cohort study addressing the effect of invasive candidemia on outcomes. This study was performed in a medical-surgical ICU located in a tertiary private hospital in São Paulo, Brazil. Data was collected through the review of the hospital database. Results In total, 18,442 patients were included in our study, including 22 patients with candidemia. The median age was similar in patients with and without candidemia [67 (56–84) vs. 67 (51–80)]. Most patients were male, and the proportion of men was higher among patients with candidemia (77% vs. 55.3%). The rates of renal replacement therapy (40.9% vs. 3.3%), mechanical ventilation (63.6% vs. 29.6%), and parenteral nutrition (40.9% vs. 4.8%) were higher in patients with candidemia than in those without candidemia. The mortality rate (77.3% vs. 11.9%) and length of hospital stay [42 days (23.0–78.8) vs. 8 days (5.0–17.0)] were significantly higher in patients with candidemia. Conclusions Patients with candidemia are prone to longer hospital stay and mortality. In addition, we found associations of candidemia with the use of invasive mechanical ventilation, renal replacement therapy, and parenteral nutrition.

[1]  A. Christe,et al.  Risk factors for candidemia: a prospective matched case-control study , 2020, Critical Care.

[2]  A. Gorelik,et al.  Risk factors for candidaemia and their cumulative effect over time in a cohort of critically ill, non-neutropenic patients. , 2018, Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine.

[3]  F. Guo,et al.  Epidemiology, clinical characteristics, and risk factors for mortality of early- and late-onset invasive candidiasis in intensive care units in China , 2017, Medicine.

[4]  E. Seminari,et al.  A prospective multicentre study of the epidemiology and outcomes of bloodstream infection in cirrhotic patients. , 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[5]  A. Valachis,et al.  Factors Influencing Non-albicans Candidemia: A Case–Case–Control Study , 2017, Mycopathologia.

[6]  G. Lyon,et al.  The epidemiology and outcomes of invasive Candida infections among organ transplant recipients in the United States: results of the Transplant‐Associated Infection Surveillance Network (TRANSNET) , 2016, Transplant infectious disease : an official journal of the Transplantation Society.

[7]  R. Rajendran,et al.  A Prospective Surveillance Study of Candidaemia: Epidemiology, Risk Factors, Antifungal Treatment and Outcome in Hospitalized Patients , 2016, Front. Microbiol..

[8]  A. Perner,et al.  Focus on infection and sepsis in intensive care patients , 2016, Intensive Care Medicine.

[9]  S. Bailly,et al.  Systemic antifungal therapy for proven or suspected invasive candidiasis: the AmarCAND 2 study , 2016, Annals of Intensive Care.

[10]  M. H. Nguyen,et al.  Clinical perspectives on echinocandin resistance among Candida species , 2015, Current opinion in infectious diseases.

[11]  C. Clancy,et al.  Rate of FKS Mutations among Consecutive Candida Isolates Causing Bloodstream Infection , 2015, Antimicrobial Agents and Chemotherapy.

[12]  M. Wolff,et al.  Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002–2010) , 2014, Intensive Care Medicine.

[13]  F. Queiroz-Telles,et al.  Prognostic factors and historical trends in the epidemiology of candidemia in critically ill patients: an analysis of five multicenter studies sequentially conducted over a 9-year period , 2014, Intensive Care Medicine.

[14]  J. Guinea.  Global trends in the distribution of Candida species causing candidemia. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[15]  R. Lynfield,et al.  Multistate point-prevalence survey of health care-associated infections. , 2014, The New England journal of medicine.

[16]  N. Yapar.  Epidemiology and risk factors for invasive candidiasis , 2014, Therapeutics and clinical risk management.

[17]  J. Rello,et al.  Epidemiology, Species Distribution, Antifungal Susceptibility, and Outcome of Candidemia across Five Sites in Italy and Spain , 2013, Journal of Clinical Microbiology.

[18]  T. Calandra,et al.  Invasive candidiasis as a cause of sepsis in the critically ill patient , 2013, Virulence.

[19]  A. Armaganidis,et al.  Invasive aspergillosis in the intensive care unit , 2012, Annals of the New York Academy of Sciences.

[20]  L. Harrison,et al.  Species Identification and Antifungal Susceptibility Testing of Candida Bloodstream Isolates from Population-Based Surveillance Studies in Two U.S. Cities from 2008 to 2011 , 2012, Journal of Clinical Microbiology.

[21]  T. Calandra,et al.  Antifungals in the ICU , 2008, Current opinion in infectious diseases.

[22]  S. Pocock,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2007, Preventive medicine.

[23]  D. Marriott,et al.  Active Surveillance of Candidemia, Australia , 2006, Emerging infectious diseases.

[24]  D. Pittet,et al.  Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  L. Saiman,et al.  Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  R. Woolson,et al.  Risk factors for hospital-acquired candidemia. A matched case-control study. , 1989, Archives of internal medicine.

[27]  P. Legrand,et al.  Diagnosis of central venous catheter-related sepsis. Critical level of quantitative tip cultures. , 1987, Archives of internal medicine.

[28]  M Rapin,et al.  Diagnosis of Central Venous Catheter-Related Sepsis: Critical Level of Quantitative Tip Cultures , 1987 .

[29]  T. Calandra,et al.  Changes in the epidemiological landscape of invasive candidiasis , 2018, The Journal of antimicrobial chemotherapy.

[30]  S. V. van Hal,et al.  Changing epidemiology of candidaemia in Australia. , 2017, The Journal of antimicrobial chemotherapy.